Autistic adults' views on the design and processes within randomised controlled trials: The APRiCoT study.
- Resource Type
- Academic Journal
- Authors
- Beasant L; University of Bristol, UK.; Realpe A; University of Bristol, UK.; Bristol NIHR Biomedical Research Centre, UK.; Douglas S; Autistic Researcher, UK.; Kenny L; Autistica, UK.; Rai D; University of Bristol, UK.; Bristol NIHR Biomedical Research Centre, UK.; Avon and Wiltshire Mental Health Partnership NHS Trust, UK.; Mills N; University of Bristol, UK.
- Source
- Publisher: Sage Publications In Association With The National Autistic Society Country of Publication: England NLM ID: 9713494 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1461-7005 (Electronic) Linking ISSN: 13623613 NLM ISO Abbreviation: Autism Subsets: MEDLINE
- Subject
- Language
- English
Lay Abstract: Large randomised controlled trials are used to test healthcare treatments. Yet there are no large randomised controlled trials on effective treatments for common mental health issues affecting autistic adults. The purpose of this study was to learn what autistic adults think about randomised controlled trials in preparation for a randomised controlled trial testing a medication for anxiety. This means we wanted to know their opinions about the way randomised controlled trials are done, such as how people are chosen to be in the study and how the study is carried out. We did this by talking to 49 autistic adults individually and asking them questions. We found that most of the people we talked to were okay with the way randomised controlled trials are done. They thought it was fair and they liked that it was based on evidence. However, some autistic people might find it hard to take part in randomised controlled trials. Some people did not like the uncertainty of not knowing what treatment they would receive in a randomised controlled trial. Others felt too vulnerable and may have had bad experiences with healthcare in the past. We found that it is important to involve autistic people early on and at every stage when designing a clinical trial. Care about how clear and precise the study communication is will build trust and improve access to research. Our study indicates that it is possible to conduct large randomised controlled trials with and for autistic people. This can ultimately contribute to the improvement of healthcare outcomes for this population.
Competing Interests: Declaration of conflicting interestsThe author(s) declared no potential conflicts of interest with respect to the research, authorship and/or publication of this article.